SLC16A10 and type 2 diabetes mellitus: There was an inverse association with type 2 diabetes risk per SD increase in ln-transformed tyrosine/methionine ratio (beta = −0.141; OR = 0.87 (0.81–0.93)) when including one genome-wide significant instrument located in SLC16A10 (Table 3, Tables S2 and S3).